Neuroligin: Difference between revisions
Michal Harel (talk | contribs) No edit summary |
Michal Harel (talk | contribs) No edit summary |
||
(11 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
<StructureSection load='' size='350' side='right' scene='42/422448/Cv/2' caption='Dimer of two mouse neuroligin-1 cholinesterase-like domains (magenta and cyan) in complex with two neurexin-beta1 LNS6 domains (salmon and yellow) and Ca+2 ions (green) [[3b3q]]'> | |||
Line 30: | Line 11: | ||
*'''NLGN-1''' regulates spines and synaptic plasticity<ref>PMID:26880202</ref>. <br /> | *'''NLGN-1''' regulates spines and synaptic plasticity<ref>PMID:26880202</ref>. <br /> | ||
*'''NLGN-2''' is localized to inhibitory synapses<ref>PMID:15540461</ref>. <br /> | *'''NLGN-2''' is localized to inhibitory synapses<ref>PMID:15540461</ref>. <br /> | ||
*'''NLGN-3''' is a synapse organizer which shapes normal function and autism disorder<ref>PMID:17897391</ref>. <br /> | |||
*'''NLGN-4''' is localized to glyceric post-synapses and regulates retina inhibition<ref>PMID:21282647</ref>. <br /> | *'''NLGN-4''' is localized to glyceric post-synapses and regulates retina inhibition<ref>PMID:21282647</ref>. <br /> | ||
Line 35: | Line 17: | ||
Mutations in NLGN 4 are associated with autism and mental retardation<ref>PMID:19726642</ref>. | Mutations in NLGN 4 are associated with autism and mental retardation<ref>PMID:19726642</ref>. | ||
== Structural insights == | |||
The <scene name='42/422448/Cv/5'>NLGN-NRXN complex involves the octahedrally coordinated Ca+2 ion</scene><ref>PMID:18084303</ref>. Water molecules are shown as red spheres. | |||
</StructureSection> | |||
== 3D Structures of Neuroligin == | == 3D Structures of Neuroligin == | ||
Line 42: | Line 27: | ||
* Neuroligin | * Neuroligin | ||
**[[5ojk]] - hNLGN-1 cholinesterase domain - human<br /> | |||
**[[3bix]] - rNLGN-1 cholinesterase domain - rat<br /> | |||
**[[8gs4]] - hNLGN-2 – Cryo EM<br /> | |||
**[[3bl8]] - mNLGN-2 cholinesterase domain – mouse<br /> | **[[3bl8]] - mNLGN-2 cholinesterase domain – mouse<br /> | ||
**[[7cee]] - mNLGN-3 cholinesterase domain<br /> | |||
**[[3be8]] - hNLGN-4 cholinesterase domain – human<br /> | **[[3be8]] - hNLGN-4 cholinesterase domain – human<br /> | ||
* Neuroligin+neurexin | * Neuroligin+neurexin | ||
Line 52: | Line 40: | ||
**[[3biw]] - rNLGN-1 cholinesterase domain+NRXN-1β LNS domain<br /> | **[[3biw]] - rNLGN-1 cholinesterase domain+NRXN-1β LNS domain<br /> | ||
**[[3vkf]] - rNLGN-1 cholinesterase domain + bNRXN-1β LNS domain | **[[3vkf]] - rNLGN-1 cholinesterase domain + bNRXN-1β LNS domain | ||
*NLGN other complexes | |||
**[[5oj6]] - rNLGN-1 cholinesterase domain + MDGA1<br /> | |||
**[[5v5v]] - rNLGN-2 cholinesterase domain + MDGA1<br /> | |||
**[[5xeq]] - rNLGN-2 cholinesterase domain (mutant) + MDGA1<br /> | |||
**[[7ceg]] - mNLGN-3 cholinesterase domain + PTP d<br /> | |||
}} | }} | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] |